Vyera Pharmaceuticals, LLC

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis And Ionis Build On Earlier Akc

The case against Martin Shkreli and his company is notorious in the annals of pharmaceutical antitrust litigation. But while the outcome puts a spotlight on strategies to block generic competition, it

The Federal Trade Commission should use its rulemaking authority to address anticompetitive pharmaceutical industry practices like “rebate walls,” FTC Acting Chair Rebecca Slaughter and fellow Democra

The US Federal Trade Commission is undergoing a shakeup with the resignation of chair Joseph Simons and the nomination of Rohit Chopra to head the Consumer Financial Protection Bureau. Their replaceme